169 related articles for article (PubMed ID: 24484536)
1. Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone.
Gaafar PM; Abdallah OY; Farid RM; Abdelkader H
J Liposome Res; 2014 Sep; 24(3):204-15. PubMed ID: 24484536
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
3. Ocular bioavailability of topical prednisolone preparations.
Olejnik O; Weisbecker CA
Clin Ther; 1990; 12(1):2-11. PubMed ID: 2328525
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment.
Elbialy NS; Abdol-Azim BM; Shafaa MW; El Shazly LH; El Shazly AH; Khalil WA
J Biomed Nanotechnol; 2013 Dec; 9(12):2105-16. PubMed ID: 24266264
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
Manosroi A; Jantrawut P; Manosroi J
Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
[TBL] [Abstract][Full Text] [Related]
6. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
[TBL] [Abstract][Full Text] [Related]
7. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
[TBL] [Abstract][Full Text] [Related]
8. Design and characterization of ofloxacin niosomes.
Ramalingam N; Natesan G; Dhandayuthapani B; Perumal P; Balasundaram J; Natesan S
Pak J Pharm Sci; 2013 Nov; 26(6):1089-96. PubMed ID: 24191311
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
10. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
Abdelkader H; Ismail S; Kamal A; Alany RG
Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
[TBL] [Abstract][Full Text] [Related]
11. Effect of formulation compositions on niosomal preparations.
Chaw CS; Kim KY
Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
[TBL] [Abstract][Full Text] [Related]
12. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of prednisolone acetate suspensions.
Roberts CW; Nelson PL
J Ocul Pharmacol Ther; 2007 Apr; 23(2):182-7. PubMed ID: 17444806
[TBL] [Abstract][Full Text] [Related]
14. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
Emad Eldeeb A; Salah S; Ghorab M
Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
[TBL] [Abstract][Full Text] [Related]
15. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.
Gugleva V; Titeva S; Rangelov S; Momekova D
Int J Pharm; 2019 Aug; 567():118431. PubMed ID: 31207279
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S
J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593
[TBL] [Abstract][Full Text] [Related]
17. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
[TBL] [Abstract][Full Text] [Related]
18. Liposomal diltiazem HCl as ocular drug delivery system for glaucoma.
Mokhtar Ibrahim M; Tawfique SA; Mahdy MM
Drug Dev Ind Pharm; 2014 Jun; 40(6):765-73. PubMed ID: 23570512
[TBL] [Abstract][Full Text] [Related]
19. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
20. Development of new ophthalmic suspension prednisolone acetate 1%.
Akram M; Shyum SB; Gauhar S
Pak J Pharm Sci; 2010 Apr; 23(2):149-54. PubMed ID: 20363691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
